JohnHallFarleyMD

Obstetrics & Gynecology • Phoenix, AZ

Gynecologic Oncology

Physician

Join to view full profile

Dr. Farley is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Farley's full profile

Already have an account?

Office
625 N 6th St
Phoenix, AZ 85004
Phone+1 602-406-8222

Fax+1 602-406-0682

Education & Training

National Capital ConsortiumResidency, Obstetrics and Gynecology, 1990 - 1994
UniforMed Services University of the Health Sciences F. Edward Hebert School of MedicineClass of 1990
National Capital ConsortiumFellowship, Gynecologic Oncology

Certifications & Licensure

AZ State Medical License 2011 - 2026
PA State Medical License 1992 - 2016
MD State Medical License 2008 - 2014
DC State Medical License 2008 - 2013
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

Fellow (FACS) American College of Surgeons

Clinical Trials

Cetuximab and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer Start of enrollment: 2004 Sep 01
Completed
Phase 2
Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer Start of enrollment: 2005 Jan 01
Completed
Phase 1
Evaluation of Vasopressin in the Vessels of Ovarian Neoplasms Start of enrollment: 2004 Mar 01
Completed
Not Applicable
Selumetinib Sulfate in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum Cancer Start of enrollment: 2007 Dec 17
Completed
Phase 2
Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III-IV Clear Cell Ovarian Cancer Start of enrollment: 2010 Aug 01
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

1 citations
Survival disparities in non-Hispanic Black and White cervical cancer patients vary by histology and are largely explained by modifiable factors.
Calen W Kucera, Nicole P Chappell, Chunqiao Tian, Michael T Richardson, Christopher M Tarney
Gynecologic Oncology. 2024-05-01
Racial, ethnic and country of origin disparities in aggressive endometrial cancer histologic subtypes.
Stuart S Winkler, Chunqiao Tian, Yovanni Casablanca, Nicholas W Bateman, Suzanne Jokajtys
Gynecologic Oncology. 2024-05-01
1 citations
Disease progression, survival, and molecular disparities in Black and White patients with endometrioid endometrial carcinoma in real-world registries and GOG/NRG oncol...
Zachary A Kopelman, Chunqiao Tian, Jordyn Tumas, Neil T Phippen, Christopher M Tarney
Gynecologic Oncology. 2024-04-01

Press Mentions

Eli Lilly’s Covid-19 Drug Bamlanivimab Is No Longer Distributed in 3 States Because of a Variant, Woodcock SaysMarch 17th, 2021
Doctors: Risk of Death from Cervical Cancer Higher Than We ThoughtJanuary 26th, 2017
Researchers Discover Breakthrough in Ovarian CancerFebruary 10th, 2016

Professional Memberships

American College of Surgeons - ACS
Member